MedTrace Logo

Microbiome Test for the Detection of Colorectal Polyps

NCT05060757 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2021-09-29

No results posted yet for this study

Summary

The main goal of this trial is to validate a new method for colorectal polyp screening based on stool microbiome signatures. 600 Individuals who are scheduled / planned to undergo a colonoscopy will be recruited for this study and a stool sample and an optional saliva sample will be collected.

Analyze process will be conducted on the microbiome of the samples given.

Conditions

  • Colon Polyp

Interventions

DIAGNOSTIC_TEST

biotax

patients who are scheduled to undergo colonoscopy will be asked to participate and give a stool sample

Sponsors & Collaborators

  • Biotax Labs LTD

    lead INDUSTRY

Principal Investigators

  • Zohar Levi, MD · Assuta Medical Center

  • Erez Hasnis, MD · Rambam Health Care Campus

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-27
Primary Completion
2022-07-31
Completion
2022-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05060757 on ClinicalTrials.gov